Grail is a healthcare company focused on multi-cancer early detection through innovative genomic technologies, including the Galleri test, which can detect over 50 types of cancers from a single blood draw
Grail is a healthcare company focused on multi-cancer early detection through innovative genomic technologies, including the Galleri test, which can detect over 50 types of cancers from a single blood draw.
The top three firms on F4's Biotech & Life Sciences investor list.